Caphosol®Mouth Rinse is suitable for temporary or persistent dryness of the mouth and throat (decreased saliva secretion, dry mouth), and other symptoms. It can be used as an adjunct to standard oral care for the prevention and treatment of oral mucositis caused by radiotherapy or high dose chemotherapy. It has been approved for marketing in 48 countries around the world currently, Caphosol®demonstrated good clinical efficacy and safety for the prevention and treatment of oral mucositis.
The incidence of oral mucositis varies among cancer patients. According to the data from cancer care associations, oral mucositis affects almost all patients receiving radiation therapy for head and neck cancer, nearly 80% of the patients receiving hematopoietic stem cell transplantation and nearly half (40%) of the patients receiving standard chemotherapy.